Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
What's New
Your Valuation
Loading...
Community
/
Switzerland
/
Pharmaceuticals & Biotech
/
Kuros Biosciences
Create a narrative
Kuros Biosciences Community
SWX:KURN Community
0
Narratives
written by author
0
Comments
on narratives written by author
8
Fair Values set
on narratives written by author
Community Investing Ideas
Kuros Biosciences
Popular
Undervalued
Overvalued
There are no community narratives available.
Your Valuation for
KURN
KURN
Kuros Biosciences
Your Fair Value
CHF
Current Price
CHF 27.64
8.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-18m
309m
2015
2018
2021
2024
2025
2027
2030
Revenue CHF 308.8m
Earnings CHF 65.9m
Advanced
Set Fair Value